Ayala Pharmaceuticals Inc (ADXS)
0.625
+0.09
(+17.81%)
USD |
OTCM |
May 08, 16:00
Ayala Pharmaceuticals 1 Year Total Returns (Daily): -40.48% for May 8, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 08, 2024 | -40.48% |
May 07, 2024 | -44.16% |
May 06, 2024 | -42.11% |
May 03, 2024 | -14.62% |
May 02, 2024 | -48.50% |
May 01, 2024 | -38.75% |
April 30, 2024 | -42.17% |
April 29, 2024 | -42.17% |
April 26, 2024 | -52.97% |
April 25, 2024 | -55.65% |
April 24, 2024 | -58.14% |
April 23, 2024 | -58.30% |
April 22, 2024 | -55.83% |
April 19, 2024 | -53.87% |
April 18, 2024 | -54.03% |
April 17, 2024 | -47.94% |
April 16, 2024 | -49.50% |
April 15, 2024 | -47.82% |
April 12, 2024 | -44.33% |
April 11, 2024 | -48.62% |
April 10, 2024 | -54.81% |
April 09, 2024 | -55.15% |
April 08, 2024 | -50.88% |
April 05, 2024 | -53.31% |
April 04, 2024 | -53.31% |
Date | Value |
---|---|
April 03, 2024 | -49.84% |
April 02, 2024 | -48.80% |
April 01, 2024 | -48.80% |
March 28, 2024 | -52.59% |
March 27, 2024 | -46.56% |
March 26, 2024 | -47.41% |
March 25, 2024 | -53.33% |
March 22, 2024 | -55.88% |
March 21, 2024 | -57.86% |
March 20, 2024 | -57.14% |
March 19, 2024 | -59.86% |
March 18, 2024 | -61.46% |
March 15, 2024 | -61.73% |
March 14, 2024 | -55.63% |
March 13, 2024 | -60.00% |
March 12, 2024 | -56.47% |
March 11, 2024 | -57.65% |
March 08, 2024 | -56.87% |
March 07, 2024 | -53.53% |
March 06, 2024 | -58.33% |
March 05, 2024 | -55.80% |
March 04, 2024 | -51.42% |
March 01, 2024 | -35.85% |
February 29, 2024 | -33.77% |
February 28, 2024 | -33.77% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-98.53%
Minimum
Sep 05 2019
81.09%
Maximum
Mar 15 2021
-55.67%
Average
-74.47%
Median
Jan 06 2020
1 Year Total Returns (Daily) Benchmarks
NovaBay Pharmaceuticals Inc | -90.82% |
Palatin Technologies Inc | -9.29% |
iBio Inc | -91.20% |
Theriva Biologics Inc | -42.68% |
Oragenics Inc | -56.79% |